Solange Corriol‐Rohou

522 total citations
19 papers, 124 citations indexed

About

Solange Corriol‐Rohou is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and Speech and Hearing. According to data from OpenAlex, Solange Corriol‐Rohou has authored 19 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 10 papers in Economics and Econometrics and 4 papers in Speech and Hearing. Recurrent topics in Solange Corriol‐Rohou's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical studies and practices (9 papers) and Adolescent and Pediatric Healthcare (4 papers). Solange Corriol‐Rohou is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical studies and practices (9 papers) and Adolescent and Pediatric Healthcare (4 papers). Solange Corriol‐Rohou collaborates with scholars based in France, United States and Switzerland. Solange Corriol‐Rohou's co-authors include S. Y. Amy Cheung, Sebastian Haertter, Christina Bucci‐Rechtweg, Raafat Bishai, Thierry Troosters, Judith García‐Aymerich, Amy Cheung, Milo A. Puhan, Jing Liu and Steven J. Kovacs and has published in prestigious journals such as Journal of Clinical Oncology, Nature Reviews Drug Discovery and Thorax.

In The Last Decade

Solange Corriol‐Rohou

16 papers receiving 121 citations

Peers

Countries citing papers authored by Solange Corriol‐Rohou

Since Specialization

Citations

This map shows the geographic impact of Solange Corriol‐Rohou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solange Corriol‐Rohou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solange Corriol‐Rohou more than expected).

Fields of papers citing papers by Solange Corriol‐Rohou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Solange Corriol‐Rohou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solange Corriol‐Rohou. The network helps show where Solange Corriol‐Rohou may publish in the future.

Co-authorship network of co-authors of Solange Corriol‐Rohou

This figure shows the co-authorship network connecting the top 25 collaborators of Solange Corriol‐Rohou. A scholar is included among the top collaborators of Solange Corriol‐Rohou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Solange Corriol‐Rohou. Solange Corriol‐Rohou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Basket trials in rare diseases: a systematic review of current practices, methodological challenges, and future directions 2025 ·Orphanet Journal of Rare Diseases ·(unknown), Solange Corriol‐Rohou, Teresinha Evangelista, (unknown), (unknown), Xavier Nissan, Alexandre Méjat	0
2	The Rare Disease Moonshot: Paradigms Shift, Translational Medicine, and Regulatory Science for the World's Rarest Conditions 2024 ·Clinical Pharmacology & Therapeutics ·(unknown), Solange Corriol‐Rohou, Marta del Álamo, (unknown), (unknown), Mathieu Boudes, Antón Ussi, K. Viel, R. Michael Linden, (unknown)	0
3	Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group‐Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the Future 2024 ·Clinical Pharmacology & Therapeutics ·Rajesh Krishna, (unknown), Solange Corriol‐Rohou, S. Y. Amy Cheung, (unknown), Satyendra Suryawanshi	2
4	Growing wiser with age: Results from the ACCELERATE Fostering Age Inclusive Research Group clinical trial survey. 2023 ·Journal of Clinical Oncology ·(unknown), (unknown), Maud Toulmonde, (unknown), (unknown), Christina Bucci‐Rechtweg, Gianluca Rossato, Martin Elliott, Mark W. Kieran, Stergios Zacharoulis, Solange Corriol‐Rohou, Lynley V. Marshall, Nathalie Gaspar	1
5	Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation 2022 ·Therapeutic Innovation & Regulatory Science ·Thomas R. Fleming, Christine Garnett, Laurie S. Conklin, Solange Corriol‐Rohou, S. Hariharan, Daphne T. Hsu, Guenther Mueller‐Velten, Yeruk Mulugeta, Ronald J. Portman, Mark D. Rothmann, Norman Stockbridge, Simon Wandel, Jialü Zhang, Lynne Yao	10
6	On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: A regulatory perspective 2022 ·Frontiers in Medicine ·Marco Viceconti, Maria Tome, (unknown), (unknown), (unknown), Claudia Mazzà, Brian Caulfield, Judith García‐Aymerich, Clemens Becker, Walter Maetzler, Thierry Troosters, Basil Sharrack, Giorgio Davico, Solange Corriol‐Rohou, Lynn Rochester	12
7	Use of pharmacodynamic modeling for Bayesian information borrowing in pediatric clinical trials 2022 ·Journal of Biopharmaceutical Statistics ·(unknown), S.Y. Amy Cheung, Solange Corriol‐Rohou, Margaret Gamalo, (unknown), Rajesh Krishna, Jing Liu	2
8	Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments 2021 ·Thorax ·Judith García‐Aymerich, Milo A. Puhan, Solange Corriol‐Rohou, Corina de Jong, Heleen Demeyer, Fabienne Dobbels, Damijan Eržen, Anja Frei, Elena Gimeno‐Santos, Nicholas S Hopkinson, Nathalie Ivanoff, Niklas Karlsson, Zafeiris Louvaris, Michael I. Polkey, Roberto Rabinovich, Mario Scuri, Maggie Tabberer, Ioannis Vogiatzis, Thierry Troosters	23
9	Optimizing Pediatric Medicine Developments in the European Union Through Pragmatic Approaches 2021 ·Clinical Pharmacology & Therapeutics ·(unknown), (unknown), Fawzi Benzaghou, Solange Corriol‐Rohou, (unknown), (unknown), (unknown), (unknown), Craig Johnson, (unknown), Richard J. Vart, (unknown), Thomas C. Kühler	4
10	Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving? 2021 ·Age and Ageing ·Simon U. Jaeger, (unknown), Daniel Schoene, Roman Tremmel, Michael Chambers, Letizia Leocani, Solange Corriol‐Rohou, Jochen Klenk, Basil Sharrack, Judith García‐Aymerich, Lynn Rochester, Walter Maetzler, Milo A. Puhan, Matthias Schwab, Clemens Becker	5
11	Shared Learnings on the New EMA First-in-Human and Early Clinical Trial Guideline: Proceedings From a DIAlogue Session at DIA Europe 2018 2020 ·Therapeutic Innovation & Regulatory Science ·Jan Willem van der Laan, Charles Benson, (unknown), (unknown), (unknown), (unknown), (unknown), Solange Corriol‐Rohou, Roy Forster, Andreas Hartmann, Peter Pertel, Sarah Robertson, Beatriz Silva Lima, Raleigh Malik, Salah‐Dine Chibout	0
12	How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural Enhancement 2020 ·Therapeutic Innovation & Regulatory Science ·(unknown), Thomas Severin, (unknown), Solange Corriol‐Rohou, Christina Bucci‐Rechtweg, Kristina An Haack, Sabine Fuerst‐Recktenwald, (unknown), Ensio Norjavaara, Martine Dehlinger-Kremer, Sebastian Haertter, S. Y. Amy Cheung	5
13	Orphan Medicines for Pediatric Use: A Focus on the European Union 2019 ·Clinical Therapeutics ·(unknown), Solange Corriol‐Rohou, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Thomas C. Kühler	9
14	Industry Perspective on Using MIDD for Pediatric Studies Requiring Integration of Ontogeny 2019 ·The Journal of Clinical Pharmacology ·Solange Corriol‐Rohou, S. Y. Amy Cheung	7
15	The evolution of adaptiveness: balancing speed and evidence 2018 ·Nature Reviews Drug Discovery ·Hans‐Georg Eichler, Richard Barker, (unknown), Jacoline C. Bouvy, André W. Broekmans, Anna Bucsics, Francesca Cerreta, Solange Corriol‐Rohou, Alı́cia Granados, Yann Le Cam, Ad Schuurman	6
16	Medicines Adaptive Pathways to Patients: Why, When, and How to Engage? 2018 ·Clinical Pharmacology & Therapeutics ·Hans‐Georg Eichler, (unknown), Mathieu Boudes, Jacoline C. Bouvy, André W. Broekmans, Francesca Cerreta, Stuart Faulkner, (unknown), (unknown), Yann Le Cam, (unknown), (unknown), Solange Corriol‐Rohou	7
17	Recognizing that Evidence is Made, not Born 2018 ·Clinical Pharmacology & Therapeutics ·Robyn Lim, (unknown), (unknown), John Ferguson, Marilyn Metcalf, Meredith Y. Smith, Solange Corriol‐Rohou, Hans‐Georg Eichler, Murray Lumpkin, Gigi Hirsch, (unknown), Brian O’Rourke, Anja Schiel, (unknown), Naomi Aronson, Edmund J. Pezalla, Marc Boutin, (unknown), (unknown)	2
18	Challenges and Opportunities in the Development of Medical Therapies for Pediatric Populations and the Role of Extrapolation 2017 ·Clinical Pharmacology & Therapeutics ·Jeffrey S. Barrett, Raafat Bishai, Christina Bucci‐Rechtweg, Amy Cheung, Solange Corriol‐Rohou, Sebastian Haertter, (unknown), Steven J. Kovacs, Jing Liu, (unknown), (unknown), (unknown)	26
19	Comparison of the analgesic and anti-inflammatory effects of topical niflumic acid gel versus piroxicam gel in the treatment of musculoskeletal disorders 1993 ·Current Therapeutic Research ·(unknown), (unknown), Solange Corriol‐Rohou	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact